Unique ID issued by UMIN | UMIN000025980 |
---|---|
Receipt number | R000029864 |
Scientific Title | Usefulness of FAMT-PET to predict the response after chemotherapy in patients withmalignant lymphoma |
Date of disclosure of the study information | 2017/02/03 |
Last modified on | 2017/02/03 02:07:00 |
Usefulness of FAMT-PET to predict the response after chemotherapy in patients withmalignant lymphoma
FAMT-PET and prediction of chemotherapy in malignant lymphomna
Usefulness of FAMT-PET to predict the response after chemotherapy in patients withmalignant lymphoma
FAMT-PET and prediction of chemotherapy in malignant lymphomna
Japan |
malignant lymphoma
Hematology and clinical oncology | Radiology |
Malignancy
NO
FDG-PET yields a false positive finding to cancer diagnosis and detection. FAMT-PET is a tumor specific PET , nicely differring malignancy and inflammatory lesions. Therefore, we conducted the clinical study to evaluate FAMT-PET as a predictor of chemotherapy.
Others
To monitor the outcome after treatment
Exploratory
Pragmatic
Not applicable
Changeing of SUVmax, MTV and TLG, and the efficacy of chemotherapy
Evaluation after 2 cycles from initial chemotherapy
Survival and adverse events
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Diagnosis
Device,equipment |
All patients undergo FAMT-PET/MRI before and 2 cycles after chemotherapy
20 | years-old | <= |
Not applicable |
Male and Female
1) Pathologically confirmed malignant lymphoma, chemo-naive case.
2) Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
3) Patient with evaluable lesion based on RECIST
4) Written informed consent
1) Pregnant woman
2) Patients with obvious interstitial pneumonia or pulmonary fibrosis in the chest X-ray.
3) Patients with collagen vascular disease or autoimmune diseases
4) Other cases attending physician it is determined unsuitable for registration of the study
80
1st name | |
Middle name | |
Last name | Norifumi Tsukamoto |
Gunma Univetsity Hospital
Oncology Center
3-39-15, showa-machi, Maebashi, Gunma
027-220-8529
tsukamoto@gunma-u.ac.jp
1st name | |
Middle name | |
Last name | Kyoichi Kaira |
Gunma Univetsity Hospital
Oncology Clinical Development
3-39-15, showa-machi, Maebashi, Gunma
027-220-8222
kkaira1970@yahoo.co.jp
Gunma Univetsity
Gunma Univetsity
Self funding
NO
2017 | Year | 02 | Month | 03 | Day |
Unpublished
2017 | Year | 01 | Month | 31 | Day |
2017 | Year | 02 | Month | 01 | Day |
2017 | Year | 02 | Month | 03 | Day |
2017 | Year | 02 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029864
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |